Physician profile
Deepak Vasishtha
NPI 1114950540
$1,072.11
in general payments reported to CMS, 2019-2025
13 companies · $66.78 in 2025
The $66.78 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $112 · 2021: $277 · 2022: $55.82 · 2023: $191 · 2024: $169 · 2025: $66.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $367.64 | 2019-2025 | Xtampza, Belbuca |
| Horizon Therapeutics Plc | $247.74 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $93.38 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $76.65 | 2022-2023 | Seglentis |
| Astrazeneca Pharmaceuticals LP | $64.09 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.76 | 2021-2023 | Relistor |
| Depuy Synthes Sales INC. | $40.17 | 2019-2023 | Orthovisc |
| Biodelivery Sciences International, INC. | $34.26 | 2021 | |
| Pfizer INC. | $32.76 | 2020 | |
| Neurocrine Biosciences, INC. | $27.92 | 2022 | |
| Orthofix Medical, INC. | $16.83 | 2021 | |
| Otto Bock Healthcare LP | $13.00 | 2020 | |
| Assertio Therapeutics, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Vasishtha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.